Anti rankl project for avascular necrosis of bone

Trial Profile

Anti rankl project for avascular necrosis of bone

Phase of Trial: Phase II

Latest Information Update: 03 Jul 2018

At a glance

  • Drugs Denosumab (Primary)
  • Indications Osteonecrosis
  • Focus Adverse reactions
  • Most Recent Events

    • 27 Jun 2018 Status changed from not yet recruiting to discontinued.
    • 28 Jun 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top